|
Volumn 110, Issue 1, 2007, Pages 2-4
|
The evolving prenatal screening scene
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHORIONIC GONADOTROPIN;
CHORIONIC GONADOTROPIN BETA SUBUNIT;
ESTRIOL;
INHIBIN A;
PREGNANCY ASSOCIATED PLASMA PROTEIN A;
AMNIOCENTESIS;
CLINICAL PRACTICE;
COST EFFECTIVENESS ANALYSIS;
DOWN SYNDROME;
EDITORIAL;
FIRST TRIMESTER PREGNANCY;
HEALTH CARE ORGANIZATION;
HIGH RISK POPULATION;
HUMAN;
LABORATORY DIAGNOSIS;
MEDICAL DECISION MAKING;
PATIENT COUNSELING;
PREGNANT WOMAN;
PRENATAL SCREENING;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SECOND TRIMESTER PREGNANCY;
CLINICAL TRIALS;
COST-BENEFIT ANALYSIS;
DOWN SYNDROME;
FEMALE;
HUMANS;
MASS SCREENING;
PRACTICE GUIDELINES;
PREGNANCY;
PRENATAL DIAGNOSIS;
UNITED STATES;
|
EID: 34347355595
PISSN: 00297844
EISSN: None
Source Type: Journal
DOI: 10.1097/01.AOG.0000269044.84174.fc Document Type: Editorial |
Times cited : (6)
|
References (6)
|